Repligen Corp.

Repligen is a provider of bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The company's bioprocessing business is comprised of: Chromatography, which includes products used in the downstream purification and quality control of biological drugs; Filtration, which include KrosFlo? line of hollow-fiber cartridges and tangential flow filters systems, the Spectra/Por? portfolio of laboratory and process dialysis products and Pro-Connex? single-use hollow-fiber Module-Bag-Tubing sets; and OEM Products (Proteins), which are a component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products.
  • TickerRGEN
  • ISINUS7599161095
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

• A number of Healthcare names are pulling back to logical support areas. (ex. EW, EGRX, ARWR, RGEN, LCI, CTLT, and PBH) • The Technology Sector continues to have a number of technically attractive names that are pulling back to support levels. (ex. FORM, MKSI, NVDA, MU, SYNA, ANSS, COHR, and WDC) • Defensive Sectors such REITs and Consumer Staples remain leadership. (ex. LW, PEP, UHT, NSA, COR, and LSI)

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

1 director sold

A director at Repligen Corp sold 12,094 shares at 82.398USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board ...

1 director sold

A director at Repligen Corp sold 12,094 shares at 82.398USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board ...

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

• A number of Healthcare names are pulling back to logical support areas. (ex. EW, EGRX, ARWR, RGEN, LCI, CTLT, and PBH) • The Technology Sector continues to have a number of technically attractive names that are pulling back to support levels. (ex. FORM, MKSI, NVDA, MU, SYNA, ANSS, COHR, and WDC) • Defensive Sectors such REITs and Consumer Staples remain leadership. (ex. LW, PEP, UHT, NSA, COR, and LSI)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Homebuilders continue to be leadership. (ex. MTH, PHM, and MHO) • A number of Transportation Sector names are staging price and RS reversals, or remain leadership. (ex. XPO, JBLU, UAL, SKYW, AAL, DAL, UNP, JBHT, KNX, ODFL, LSTR, and SAIA) • Many Materials Sector names appear to be staging price and RS reversals. (ex. DOW, VVV, LYB, MLM, VMC, USCR, EMN, and CMC. )

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Gold is staging a massive breakout above the $1360 level. Major H&S bottoms can be seen across the group (ex, NEM, RGLD) • Energy related names are attempting to carve out reversals. We prefer the names that held up well during the Crude oil decline. (ex. HLX, PUMP, FTI, CKH, PSX) • A number of Biotech names are breaking out of bases and reflect RS leadership. (ex. OMCL, RGEN, INCY, and ANIP)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: Home builders and suppliers continue to outperform and one supplier, MHK, appears to be bottoming. A number of Financial names continue to plod up and to the right (e.g. AMP, AXP, MSCI, RNR) The Technology Sector remains leadership and many names continue to outperform (e.g. SEDG, SNPS, ADBE, TTEC, GPN, PYPL)

ResearchPool Subscriptions

Get the most out of your insights

Get in touch